Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1974 Jan;27(1):50–52. doi: 10.1136/jcp.27.1.50

Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine

D C E Speller 1
PMCID: PMC477985  PMID: 4856590

Abstract

Two diabetic patients with symptomatic urinary tract infection by Torulopsis glabrata were successfully treated with two-week courses of 5-fluorocytosine.

Full text

PDF
50

Images in this article

50Image
on p.50
51Image
on p.51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahearn D. G., Jannach J. R., Roth F. J., Jr Speciation and densities of yeasts in human urine specimens. Sabouraudia. 1966 Oct;5(2):110–119. doi: 10.1080/00362176785190201. [DOI] [PubMed] [Google Scholar]
  2. Davies R. R., Reeves D. S. 5-fluorocytosine and urinary candidiasis. Br Med J. 1971 Mar 13;1(5749):577–579. doi: 10.1136/bmj.1.5749.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Edebo L., Spetz A. Urinary tract infection with Torulopsis glabrata treated by alkalization of urine. Br Med J. 1965 Oct 23;2(5468):983–984. doi: 10.1136/bmj.2.5468.983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GUZE L. B., HALEY L. D. Fungus infections of the urinary tract. Yale J Biol Med. 1958 Feb;30(4):292–305. [PMC free article] [PubMed] [Google Scholar]
  5. Holt R. J., Newman R. L. The antimycotic activity of 5-fluorocytosine. J Clin Pathol. 1973 Mar;26(3):167–174. doi: 10.1136/jcp.26.3.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MACKENZIE D. W. Yeasts from human sources. Sabouraudia. 1961 Jan;1:8–15. doi: 10.1080/00362176285190051. [DOI] [PubMed] [Google Scholar]
  7. Marks M. I., Langston C., Eickhoff T. C. Torulopsis glabrata--an opportunistic pathogen in man. N Engl J Med. 1970 Nov 19;283(21):1131–1135. doi: 10.1056/NEJM197011192832103. [DOI] [PubMed] [Google Scholar]
  8. Schönebeck J., Steen L., Tärnvik A. 5-fluorocytosine treatment of candida infections of the urinary tract and other sites. Scand J Urol Nephrol. 1972;6(1):37–45. doi: 10.3109/00365597209132078. [DOI] [PubMed] [Google Scholar]
  9. Shadomy S. In vitro studies with 5-fluorocytosine. Appl Microbiol. 1969 Jun;17(6):871–877. doi: 10.1128/am.17.6.871-877.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Speller D. C., Davies M. G. Sensitivity of yeasts to 5-fluorocytosine. J Med Microbiol. 1973 Aug;6(3):315–321. doi: 10.1099/00222615-6-3-315. [DOI] [PubMed] [Google Scholar]
  11. Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med. 1972 Jan;76(1):15–22. doi: 10.7326/0003-4819-76-1-15. [DOI] [PubMed] [Google Scholar]
  12. Webb A. J., Speller D. C., Buckler K. G. Torulopsis glabrata septicaemia treated with 5-fluorocytosine. Lancet. 1970 Apr 18;1(7651):839–840. doi: 10.1016/s0140-6736(70)92438-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES